According to THE SAGE GROUP, The Majority of Endovascular Revascularizations Performed for Peripheral Artery Disease (PAD) are Outpatient October 14, 2024

According to THE SAGE GROUP, Less Than 20% of Symptomatic Peripheral Artery Disease (PAD) Patients Are Revascularized October 1, 2024

According to THE SAGE GROUP, There is a Significant Need for Innovative Endovascular Devices to Treat Below-the-Ankle (BTA) Disease in Critical Limb Ischemia (CLI) Patients September 6, 2024

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Highlights Gender Disparities in PAD September 13, 2023

According to THE SAGE GROUP, High Restenosis Rates Following Endovascular Treatment of Infrapopliteal Disease Create a Significant Need for Improved Technologies February 21, 2023

THE SAGE GROUP Comments on National Peripheral Artery Disease (PAD) Awareness Month September 14, 2022

THE SAGE GROUP Announces a New Publication on Peripheral Artery Disease in African Americans March 18, 2022

In Honor of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Costs and Consequences of the Amputation Lottery September 14, 2021

According to THE SAGE GROUP, Restenosis Remains a Significant and Costly Problem After Endovascular Treatment of Peripheral Artery Disease (PAD) March 16, 2021

According to THE SAGE GROUP, Treating Critical Limb Ischemia (CLI) with Major Amputation Costs Over $22 Billion, Results in a Significant Misallocation of Healthcare Resources and Wastes Taxpayer Dollars. May 27, 2020

THE SAGE GROUP Announces a New Publication Titled “Critical Limb Ischemia (CLI) Non-Responders: Patients Who Do Not Respond to Revascularization, Factors That Identify Non-response and Non-Responder Prevalence and Markets.” January 15, 2020

According to THE SAGE GROUP, the Annual Ecnomic Burden of Critical Limb Ischemia (CLI) Exceeds $200 Billion. July 16, 2019

According to THE SAGE GROUP, Critical Limb Ischemia (CLI) is a Major and Growing Problem. May 30, 2019

According to THE SAGE GROUP, Thrombus is Highly Prevalent in Both Symptomatic and Asymptomatic Peripheral Artery Disease (PAD) Patients. February 5, 2019

THE SAGE GROUP Announces Publication of U.S. Acute Limb Ischemia (ALI) Incidence and Market Estimates. January 17, 2019